TP53 and benign prostatic hyperplasia: Slabakova et al showed that miR-200 can counteract TGFβ1-induced EMT in benign prostate hyperplasia (BPH) cells [54]Liu et al identified that miR-200 along with miR-1 act as negative regulators of EMT in Pten and TP53 null murine models [55].